72180-27-9 Usage
Pharmaceutical Industry
Used in the development of drugs and medicines.
Therapeutic Applications
Exhibits inhibitory effects on human immunodeficiency virus (HIV) replication.
Antiviral Properties
Being studied for its potential to inhibit the growth and spread of viruses.
Antitumor Properties
Under investigation for its potential to inhibit the growth and spread of cancer cells.
Alzheimer's Disease Treatment
Being researched for its potential use in the treatment and management of Alzheimer's disease.
Chirality
(2S)indicates the compound has a specific three-dimensional arrangement of atoms, which can affect its biological activity and properties.
Ester Functionality
The presence of a carbonyl group bonded to an oxygen atom and an organic group, which can participate in various chemical reactions.
Fluorine Substitution
The presence of two fluorine atoms at the 4,4-position, which can influence the compound's reactivity, lipophilicity, and binding properties.
Phenylmethyl Ester
The presence of a phenylmethyl group (benzene ring with a CH2-) attached to the ester functionality, which can affect the compound's steric and electronic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 72180-27-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,1,8 and 0 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 72180-27:
(7*7)+(6*2)+(5*1)+(4*8)+(3*0)+(2*2)+(1*7)=109
109 % 10 = 9
So 72180-27-9 is a valid CAS Registry Number.
72180-27-9Relevant academic research and scientific papers
BENZIMIDAZOLE-LINKED INDOLE COMPOUND ACTING AS NOVEL DIVALENT IAP ANTAGONIST
-
, (2019/03/14)
The present invention discloses a benzimidazole-linked indole compound acting as novel divalent IAP antagonist, specifically disclosing the compound shown in fomulas (I) or a pharmaceutically acceptable salt thereof.
HALOGENATED SUBSTITUTED MERCAPTOACYLAMINO ACIDS
-
, (2008/06/13)
New halogen substituted mercaptoacylamino acids which have the general formula STR1 and basic salts thereof are useful as hypotensive agents.
